5-Aminopentanoic acid
|
Basic information |
| Metabolite name | 5-Aminopentanoic acid |
 | HMDB0003355 |
 |
C00431 |
 |
138 |
| Synonyms | 5-aminovaleric acid; |
| No. of studies | 11 |
|
Basic information |
| Metabolite name | 5-Aminopentanoic acid |
| HMDB0003355 |
|
C00431 |
|
138 |
| Synonyms | 5-aminovaleric acid; |
| No. of studies | 11 |
|
Relationship between 5-Aminopentanoic acid and depression (count: 11) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M042 | Type3 | fluoxetine group vs. control group | Cerebrospinal fluid | Rhesus monkey | Up |
| Study M042 | Type3 | fluoxetine group vs. control group | Plasma | Rhesus monkey | Up |
| Study M074 | Type1 | sCSDS group vs. control group | Faece | C57BL/6JJmsSlc mouse | Down |
| Study M207 | Type1 | depressed group vs. control group | Faece | Kunming mouse | Down |
| Study M572 | Type1 | major antenatal depression group vs. control group | Plasma | Human | Up |
| Study M613 | Type2 | CSDS susceptible + imipramine group vs. CSDS + vehicle group | Ventral hippocampus | C57BL/6 J mouse | Up |
| Study M633 | Type1 | corticosterone group vs. control group | Urine | C57BL/6 mouse | Down |
| Study M633 | Type2 | corticosterone + Chrysanthemum morifolium group vs. corticosterone group | Urine | C57BL/6 mouse | Up |
| Study M712 | Type1 | depression group vs. control group | Intestine | Cynomolgus monkey | Down |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Faece | BALB/c mouse | Up |
| Study M850 | Type1 | reserpine group vs. control group | Brain | C57BL/6 mouse | Up |
| Study M911 | Type1 | CUS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M953 | Type1 | CRS group vs. control group | Faece | Sprague-Dawley rat | Up |